Lidocaine jelly reduces ureteral calculus migration following lithotripsy Clinical study 02 February 2013 Pages: 15 - 15
Everolimus evades acute rejection following renal transplant News item 02 February 2013 Pages: 16 - 16
Doxorubicin-based chemo not a patch on cisplatin for SCLC Clinical study 02 February 2013 Pages: 17 - 17
Gemcitabine + paclitaxel improves survival duration in breast cancer Clinical study 02 February 2013 Pages: 17 - 17
Tacrolimus + MMF regimen effective after liver transplantation Clinical study 02 February 2013 Pages: 18 - 18
Zoledronic acid prevents osteoporosis in premenopausal chemo recipients Clinical study 02 February 2013 Pages: 19 - 19
Intrathecal gemcitabine not recommended due to neurotoxicity News item 02 February 2013 Pages: 20 - 20
Long-term PPI use increases osteoporosis-related fracture risk News item 02 February 2013 Pages: 20 - 20
Amifostine may reduce risk of cisplatin-induced ototoxicity Clinical study 02 February 2013 Pages: 21 - 21
Measles increase a result of vaccine scare, says US CDC Clinical study 02 February 2013 Pages: 21 - 21
Periocular anaesthetic injection + IV sedation: not to be sneezed at News item 02 February 2013 Pages: 21 - 21
Iclaprim Marketing Authorisation Application (MAA) accepted by EMEA. Media release 02 February 2013 Pages: 22 - 22
Lisdexamfetamine now available in three additional dosage strengths in US. Media release 02 February 2013 Pages: 22 - 22
Qiagen launches new test for adverse reactions to abacavir Media release 02 February 2013 Pages: 22 - 22
Romiplostim approved in US for chronic immune thrombocytopenic purpura. Media release 02 February 2013 Pages: 22 - 22
Tramadol receives expanded indication approval in Canada. Media release 02 February 2013 Pages: 22 - 22
US FDA requires additional data prior to approval of paliperidone. Media release 02 February 2013 Pages: 23 - 23